ZA974952B - 2'-substituted nucleosides and oligonucleotide derivatives. - Google Patents

2'-substituted nucleosides and oligonucleotide derivatives.

Info

Publication number
ZA974952B
ZA974952B ZA9704952A ZA974952A ZA974952B ZA 974952 B ZA974952 B ZA 974952B ZA 9704952 A ZA9704952 A ZA 9704952A ZA 974952 A ZA974952 A ZA 974952A ZA 974952 B ZA974952 B ZA 974952B
Authority
ZA
South Africa
Prior art keywords
oligonucleotide derivatives
substituted nucleosides
nucleoside building
building blocks
oligonucleotide
Prior art date
Application number
ZA9704952A
Other languages
English (en)
Inventor
Bernard Cuenoud
Karl-Heinz Altmann
Pierre Martin
Heinz Moser
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA974952B publication Critical patent/ZA974952B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9704952A 1996-06-06 1997-06-05 2'-substituted nucleosides and oligonucleotide derivatives. ZA974952B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH143296 1996-06-06

Publications (1)

Publication Number Publication Date
ZA974952B true ZA974952B (en) 1997-12-08

Family

ID=4210329

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9704952A ZA974952B (en) 1996-06-06 1997-06-05 2'-substituted nucleosides and oligonucleotide derivatives.

Country Status (11)

Country Link
US (2) US6670468B1 (fr)
EP (1) EP0906329B1 (fr)
JP (1) JP2000512630A (fr)
AT (1) ATE251638T1 (fr)
AU (1) AU3029797A (fr)
CA (1) CA2256765A1 (fr)
CY (1) CY2522B1 (fr)
DE (1) DE69725440T2 (fr)
DK (1) DK0906329T3 (fr)
WO (1) WO1997046569A2 (fr)
ZA (1) ZA974952B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0906329T3 (da) * 1996-06-06 2004-02-09 Novartis Ag 2'-Substituerede nukleosider og oligonukleotidderivater
US6277967B1 (en) * 1998-07-14 2001-08-21 Isis Pharmaceuticals, Inc. Carbohydrate or 2′-modified oligonucleotides having alternating internucleoside linkages
US6673912B1 (en) 1998-08-07 2004-01-06 Isis Pharmaceuticals, Inc. 2′-O-aminoethyloxyethyl-modified oligonucleotides
US6043352A (en) 1998-08-07 2000-03-28 Isis Pharmaceuticals, Inc. 2'-O-Dimethylaminoethyloxyethyl-modified oligonucleotides
DE10238722A1 (de) 2002-08-23 2004-03-11 Bayer Ag Selektive Phosphodiesterase 9A-Inhibitoren als Arzneimittel zur Verbesserung kognitiver Prozesse
US20060258691A1 (en) * 2005-05-13 2006-11-16 Joseph Barbosa Methods and compositions for improving cognition
US8648085B2 (en) 2007-11-30 2014-02-11 Boehringer Ingelheim International Gmbh 1, 5-dihydro-pyrazolo (3, 4-D) pyrimidin-4-one derivatives and their use as PDE9A mudulators for the treatment of CNS disorders
UA105362C2 (en) 2008-04-02 2014-05-12 Бьорингер Ингельхайм Интернациональ Гмбх 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
AP2011005672A0 (en) 2008-09-08 2011-04-30 Boehringer Ingelheim Int Pyrazolopyrimidines and their use for the treatment of CNS disorders.
US8975389B2 (en) * 2009-03-02 2015-03-10 Alnylam Pharmaceuticals, Inc. Nucleic acid chemical modifications
NZ594567A (en) 2009-03-31 2013-12-20 Boehringer Ingelheim Int 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
WO2012020022A1 (fr) 2010-08-12 2012-02-16 Boehringer Ingelheim International Gmbh Dérivés de 6-cycloalkyl-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-one et leurs utilisations en tant qu'inhibiteurs de pde9a
US8809345B2 (en) 2011-02-15 2014-08-19 Boehringer Ingelheim International Gmbh 6-cycloalkyl-pyrazolopyrimidinones for the treatment of CNS disorders
BR112018002399A2 (pt) 2015-08-06 2018-09-25 Chimerix, Inc. nucleosídeos de pirrolopirimidina e análogos dos mesmos, úteis como agentes antivirais
US11111264B2 (en) 2017-09-21 2021-09-07 Chimerix, Inc. Morphic forms of 4-amino-7-(3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-methyl-7H-pyrrolo[2,3-d]pyrimidine-5-carboxamide and uses thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991006556A1 (fr) * 1989-10-24 1991-05-16 Gilead Sciences, Inc. Oligonucleotides modifies en position 2'
WO1994002501A1 (fr) * 1992-07-23 1994-02-03 Isis Pharmaceuticals, Inc. Nouveaux 2'-o-alkyle nucleosides et phosporamidites, leurs procedes de preparation et d'utilisation
US5514786A (en) * 1990-01-11 1996-05-07 Isis Pharmaceuticals, Inc. Compositions for inhibiting RNA activity
WO1995006659A1 (fr) 1992-07-01 1995-03-09 Isis Pharmaceuticals, Inc. Nucleosides et oligonucleosides a fonction(s) amine
DE4037363A1 (de) 1990-04-09 1991-10-10 Europ Lab Molekularbiolog 2-0-alkylnukleotide sowie polymere, die solche nukleotide enthalten
CA2089376C (fr) 1990-08-13 2010-05-04 Phillip Dan Cook Oligonucleotides modifies par des sucres qui detectent et modulent l'expression de genes
DE4110085A1 (de) 1991-03-27 1992-10-01 Boehringer Ingelheim Int 2'-o-alkyl-oligoribonukleotide, verfahren zu deren herstellung und deren verwendung als antisense-oligonukleotide
JP2823959B2 (ja) * 1991-10-24 1998-11-11 アイシス・ファーマシューティカルス・インコーポレーテッド 改良された取り込みおよびその他の性質を持つ誘導化オリゴヌクレオチド
EP0618925B2 (fr) 1991-12-24 2012-04-18 Isis Pharmaceuticals, Inc. Oligonucleotides antisense
US5485592A (en) 1992-04-07 1996-01-16 Video Technology Computers, Ltd. Write back cache controller method and apparatus for use in a system having a CPU with internal cache memory
ES2128535T3 (es) * 1993-05-12 1999-05-16 Novartis Ag Nucleosidos y oligonucleotidos con grupos 2'-eter.
US5571902A (en) * 1993-07-29 1996-11-05 Isis Pharmaceuticals, Inc. Synthesis of oligonucleotides
ES2203635T3 (es) * 1994-04-27 2004-04-16 Novartis Ag Nucleosidos y oligonucleotidos con grupos 2'-eter.
US5744362A (en) * 1994-05-31 1998-04-28 Isis Pharmaceuticals, Inc. Antisense oligonucleotide modulation of raf gene expression
DK0906329T3 (da) * 1996-06-06 2004-02-09 Novartis Ag 2'-Substituerede nukleosider og oligonukleotidderivater

Also Published As

Publication number Publication date
DE69725440D1 (de) 2003-11-13
DK0906329T3 (da) 2004-02-09
EP0906329B1 (fr) 2003-10-08
US20050159374A1 (en) 2005-07-21
WO1997046569A2 (fr) 1997-12-11
DE69725440T2 (de) 2004-07-22
US6670468B1 (en) 2003-12-30
EP0906329A2 (fr) 1999-04-07
JP2000512630A (ja) 2000-09-26
CA2256765A1 (fr) 1997-12-11
ATE251638T1 (de) 2003-10-15
AU3029797A (en) 1998-01-05
WO1997046569A3 (fr) 1998-02-19
CY2522B1 (en) 2006-02-08

Similar Documents

Publication Publication Date Title
CY2522B1 (en) 2-Substituted nucleosides and oligonucleotide derivatives
BG106569A (en) Purine derivatives
BG106567A (en) Purine derivatives
BG106289A (en) Purine derivatives
DE60144479D1 (fr)
YU76100A (sh) Pirolo(2,3-d) pirimidin preparati i njihova primena
CA2167361A1 (fr) 2,2-difluoro-3-carbamoylriboses sulfonates et methode de preparation de beta-nucleosides
HK1003941A1 (en) Therapeutic nucleosides
IL98702A (en) 9-purinyl phosphonic acid derivatives their preparation and pharmaceutical compositions containing them
TR199900083T2 (xx) Klaritromisinin kristal bi�imi I.
EP0911321A3 (fr) Composés pour le traitement de l'ostéoporose
ZA200203102B (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing same.
MD1838F2 (en) 5,6-dichlorbenzimidazole derivatives, process for obtaining thereof, pharmaceutical composition and method of treatment or prevention of herpetic viral infections
PT1280813E (pt) Analogos de nucleosidos de pirimidina antivirais
AP9801269A0 (en) Prostaglandin agonists.
ZA9811833B (en) Pharmaceutical compositions of uridine triphosphate.
MY120683A (en) New phenylamidine derivatives, processes for their preparation and their use as pharmaceuticals.
CA2166692A1 (fr) Nouveaux nucleosides 9-n-bicycliques, agents utiles comme inhibiteurs selectifs pour les cytokines pro-inflammatoires
MY116766A (en) Improved process for antiparasitic agent
BG101163A (en) 8-fluoro-anthracyclines, processes for their preparation and pharmaceutical compositions containing them
AU5497396A (en) Process for the synthesis of nucleoside analogues
EP0828749A4 (fr) Compositions et procedes de synthese de derives organophosphoreux
YU51401A (sh) Postupak za dobijanje n6-supstituisanih derivata deaza-adenozima